Stockreport

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]

Generation Bio Co. - Common stock  (GBIO) 
PDF - Development of breakthrough immune-quiet DNA for hemophilia A program continues - Cash balance of $264.4 million expected to fund operations into 2H 2027 CAMBRIDG [Read more]